This is a randomized double-blinded placebo-controlled study to evaluate the effects of
NSK-SD consumption in subjects with Stage I hypertension.
The study population will be randomized into two groups, where both groups will receive
dietary and lifestyle recommendations to help reduce hypertension. One group will receive
placebo and the other group NSK-SD for 8 weeks.
The endpoint will be the change in systolic and diastolic blood pressure after 8 weeks of
treatment in the two subject groups.